Search Results - "Bushara, N"

Implantable and oral naltrexone for preventing relapse in opiate addicts: A psychometric evaluation by Blokhina, Elena, Krupitsky, E, Bushara, N, Yaroslavtseva, T, Tiurina, A, Palatkin, V, Verbitskaya, E, Zvartau, E, Woody, George E

Get full text

P.6.d.003 Stress-protective and anticraving effects of guanfacine in opiate dependent patients stabilized on oral naltrexone by Palatkin, V, Krupitsky, E, Zvartau, E, Blokhina, E, Bushara, N, Tyurina, A, Yaroslavtseva, T, Verbitskaya, E

Get full text

P.3.011 Risk factors for suicidal ideation among HIV-infected drinkers in Russia by Yaroslavtseva, T, Krupitsky, E, Zvartau, E, Blokhina, E, Bushara, N, Palatkin, V, Verbitskaya, E

Get full text

P.3.012 Effectiveness of naltrexone in the double blind placebo controlled clinical trial of naltrexone and guanfacine for heroin dependence by Palatkin, V, Krupitsky, E, Zvartau, E, Blokhina, E, Bushara, N, Tyurina, A, Verbitskaya, E

Get full text

Anhedonia, depression, anxiety, and craving in opioid dependent patients stabilized on oral naltrexone or naltrexone implant by Krupitsky, E M, Zvartau, E E, Blokhina, E A, Verbitskaya, E V, Wahlgren, V Yu, Tsoy-Podosenin, M V, Bushara, N M, Burakov, A M, Masalov, D V, Romanova, T N, Tiurina, A A, Palatkin, V Ya, Yaroslavtseva, T S, Sulimov, G Yu, Pecoraro, A, Woody, G

“…To assess the relationship between long-term naltrexone treatment and anxiety, depression and craving in opioid dependent individuals. Opioid dependent…”
Get more information

P.6.002 Comparative characteristics of neurocognitive functioning in patients with different types of abuse by Bushara, N, Krupitsky, E, Zvartau, E, Verbitskaya, E, Erogova, V, Tsoy, M

Get full text

P.6.012 Analysis of the impact of different forms of naltrexone on the syndrome of anhedonia and depression among heroin addicts by Tiurina, A, Krupitsky, E, Blokhina, E, Bushara, N, Palatkin, V, Zvartay, E, Burakov, A, Masalov, D, Verbitskaya, E, Woody, G

Get full text

A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine by Kibitov, А О, Krupitsky, Е М, Blokhina, Е А, Verbitskaya, Е V, Brodyansky, V М, Alekseeva, N P, Bushara, N М, Yaroslavtseva, Т S, Palatkin, V Yа, Masalov, D V, Burakov, А М, Romanova, Т N, Sulimov, G Yu, Grinenko, A Yа, Kosten, Т, Nielsen, D, Zvartau, E E

“…To evaluate an effect of opioid receptor and dopamine system gene polymorphisms on the efficacy of combined treatment with oral naltrexone and guanfacine in a…”
Get more information

P.3.04 Neurocognitive functioning in patients with different type of abuse by Bushara, N, Fishbein, D.H, Flannery, B.A, Langevin, D.J, Bobashev, G, Zvartau, E.E, Verbitskaya, E.V, Tsoy, M.V, Krupitsky, E.M, Egorova, V.U

Get full text

P.010 The association between sCD14 and neurocognitive performance during early abstinence among HIV-positive patients in Russia by Vetrova, M., Palatkin, V., Toussova, O., Blokhina, E., Krupitsky, E., Bushara, N., Yaroslavtseva, T., Letendre, S., Heaton, R., Grant, I., Hauger, R., Franklin, D.

Get full text

P.011 Prospective cohort analysis of dehydroepiandrosterone-sulfate and visuospatial memory during opioids abstinence in HIV-positive people with opioid dependence by Palatkin, V., Protsenko, E., Borovskaya, V., Irkhina, M., Toussova, O., Blokhina, E., Bushara, N., Yaroslavtseva, T., Heaton, R., Letendre, S., Grant, I., Hauger, R., Franklin, D., Vetrova, M., Krupitsky, E.

Get full text

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial by Krupitsky, Evgeny, Blokhina, Elena, Zvartau, Edwin, Verbitskaya, Elena, Lioznov, Dmitri, Yaroslavtseva, Tatiana, Palatkin, Vladimir, Vetrova, Marina, Bushara, Natalia, Burakov, Andrei, Masalov, Dmitri, Mamontova, Olga, Langleben, Daniel, Poole, Sabrina, Gross, Robert, Woody, George

“…Untreated opioid addiction in people with HIV is associated with poor HIV treatment outcomes. Slow-release, long-acting, implantable naltrexone might improve…”
Get full text